MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Sookaromdee, Pathum [1 ]
Wiwanitkit, Viroj [2 ]
机构：
[1] TWS Med Ctr, Bangkok, Thailand
[2] Dr DY Patil Univ, Pune, Maharashtra, India
来源：
TURKISH JOURNAL OF HEMATOLOGY | 2019年 / 36卷 / 03期
关键词：
MDM2; Oncogene; Copy number; Chronic lymphocytic leukemia;
D O I：
10.4274/tjh.galenos.2019.2019.0179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [31] MDM2 as a critical effector of the MYCN oncogene in tumorigenesis
    Slack, A
    Shohet, JM
    CELL CYCLE, 2005, 4 (07) : 857 - 860
  • [32] The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosis
    Bixby, Dale
    Kujawski, Lisa
    Wang, Shaomeng
    Malek, Sami N.
    CELL CYCLE, 2008, 7 (08) : 971 - 979
  • [33] Mdm2 Gene Copy Number Gain Distinguishes Aggressive From Indolent Lung Adenocarcinomas
    Zou, Y.
    Borczuk, A.
    Powell, C. A.
    Massion, P. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
    Cui, Ying
    Shao, Xiaoya
    Yang, Haiping
    Xin, Jingyi
    Liu, Yuanyuan
    Zhang, Mingxiao
    Sun, Chuanyue
    Chen, Ge
    Shen, Guomin
    Meng, Xueqiong
    Chen, Yixiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Comprehensive single nucleotide polymorphism study supports the role of MDM2 in p53-competent chronic lymphocytic leukemia
    Lucas, David M.
    Byrd, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2244 - 2245
  • [36] MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes
    Mayr, C
    Bund, D
    Schlee, M
    Bamberger, M
    Kofler, DM
    Hallek, M
    Wendtner, CM
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (01) : 44 - 53
  • [37] Genetic alterations in breast cancer associated with MDM2 dependency and sensitivity to the MDM2 inhibitor milademetan
    Bidard, Francois-Clement
    Roufai, Diana Bello
    Medford, Arielle J.
    Tirunagaru, Vijaya
    Doebele, Robert C.
    Bardia, Aditya
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma
    Segura-Sanchez, Juan
    Gonzalez-Campora, Ricardo
    Pareja-Megia, Maria Jesus
    Garcia-Escudero, Antonio
    Galera-Ruiz, Hugo
    Lopez-Beltran, Antonio
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4937 - 4942
  • [39] Mitochondrial DNA Copy Number and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Risk in Two Prospective Studies
    Kim, Christopher
    Bassig, Bryan A.
    Seow, Wei Jie
    Hu, Wei
    Purdue, Mark P.
    Huang, Wen-Yi
    Liu, Chin-San
    Cheng, Wen-Ling
    Mannisto, Satu
    Vermeulen, Roel
    Weinstein, Stephanie J.
    Lim, Unhee
    Hosgood, H. Dean
    Bonner, Matthew R.
    Caporaso, Neil E.
    Albanes, Demetrius
    Lan, Qing
    Rothman, Nathaniel
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 148 - 153
  • [40] Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia
    Fontecha, Maria Belen
    Anadon, Maria del Rosario
    Lahitou, Ines Maria Martinez
    Weich, Natalia
    Bengio, Raquel
    Moiraghi, Beatriz
    Larripa, Irene
    Fundia, Ariela Freya
    LEUKEMIA RESEARCH, 2025, 149
12345